Last reviewed · How we verify
HUMAN C1-ESTERASE INHIBITOR — Competitive Intelligence Brief
marketed
Recombinant protein
Live · refreshed every 30 min
Target snapshot
HUMAN C1-ESTERASE INHIBITOR (HUMAN C1-ESTERASE INHIBITOR).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HUMAN C1-ESTERASE INHIBITOR TARGET | HUMAN C1-ESTERASE INHIBITOR | marketed | 2011-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HUMAN C1-ESTERASE INHIBITOR CI watch — RSS
- HUMAN C1-ESTERASE INHIBITOR CI watch — Atom
- HUMAN C1-ESTERASE INHIBITOR CI watch — JSON
- HUMAN C1-ESTERASE INHIBITOR alone — RSS
Cite this brief
Drug Landscape (2026). HUMAN C1-ESTERASE INHIBITOR — Competitive Intelligence Brief. https://druglandscape.com/ci/human-c1-esterase-inhibitor. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab